Clinical evaluation of GSK576428 (fondaparinux sodium) in prevention of venous thromboembolism (VTE) after abdominal surgery.
Phase of Trial: Phase III
Latest Information Update: 14 Jul 2009
At a glance
- Drugs Fondaparinux sodium (Primary)
- Indications Thromboembolism
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 15 Oct 2008 Actual start date changed from Apr 2006 to May 2006 as reported by ClinicalTrials.gov.
- 29 Sep 2006 New trial record.